Results from a large, international, randomized, controlled trial have shown that there is a strong link between diabetics who have an abnormal heart rhythm (atrial fibrillation) and an increased risk of other heart-related problems and death. The ADVANCE study also showed that if these patients were treated with blood pressure lowering drugs, the risk was reduced: five years of active treatment would prevent one death among every 42 patients with AF.